Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ASP6432 is an antagonist of type 1 lysophosphatidic acid receptor (LPA1). For human LPA1 and rat LPA1, the IC50s are 11 nM and 30 nM , respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 8-10 weeks | $ 297.00 | |
25 mg | 8-10 weeks | $ 987.00 | |
50 mg | 8-10 weeks | $ 1,360.00 | |
100 mg | 8-10 weeks | $ 1,860.00 | |
1 mL * 10 mM (in DMSO) | 8-10 weeks | $ 413.00 |
Description | ASP6432 is an antagonist of type 1 lysophosphatidic acid receptor (LPA1). For human LPA1 and rat LPA1, the IC50s are 11 nM and 30 nM , respectively. |
Targets&IC50 | LPA1 (human):11 nM, LPA1 (rat):30 nM |
In vitro | ASP6432 inhibits proliferation of human prostate stromal cells induced by LPA. |
Molecular Weight | 599.78 |
Formula | C26H32KN4O6S2 |
CAS No. | 1282549-08-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ASP6432 1282549-08-9 GPCR/G Protein LPA Receptor ASP-6432 ASP 6432 inhibitor inhibit